Trulicity Solution for Injection in Pre-filled Pen
Dulaglutide
4.5 mg
ELI LILLY & CO INC.
| Pack size | 5 Pre-filled Pen (4.5 mg) |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 72.48 AED |
Indications
Trulicity Solution for Injection in Pre-filled Pen is used for:
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Dulaglutide :
Mechanism of Action
Dulaglutide is a human GLP-1 receptor agonist with 90% amino acid sequence homology to endogenous human GLP-1 (7-37). Dulaglutide activates the GLP-1 receptor, a membrane-bound cell-surface receptor coupled to adenylyl cyclase in pancreatic beta cells. Dulaglutide increases intracellular cyclic AMP (cAMP) in beta cells leading to glucose-dependent insulin release. Dulaglutide also decreases glucagon secretion and slows gastric emptying.
Note
Trulicity 4.5 mg Solution for Injection in Pre-filled Pen manufactured by ELI LILLY & CO INC.. Its generic name is Dulaglutide. Trulicity is availble in Saudi Arabia.
Farmaco SA drug index information on Trulicity Solution for Injection in Pre-filled Pen is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.